Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Cancer

OBJECTIVES: Granulocyte colony-stimulating factor, an agent commonly used for neutropenia treatment, plays an important role in cancer treatment. However, the effect of granulocyte colony-stimulating factor treatment on patient’s survival during radiation therapy in lung cancer remains unknown. MATE...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Technol Cancer Res Treat
Hlavní autoři: Du, Rui, Hu, Pingping, Liu, Qiqi, Zhang, Jingxin, Deng, Guodong, Hu, Dan, Zhang, Jiandong
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6295692/
https://ncbi.nlm.nih.gov/pubmed/31122176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533033818816076
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky